Home|Journals|Articles by Year|Audio Abstracts

Original Article

Turk J Vasc Surg. 2020; 29(2): 90-4

Concomitant therapies for varicose veins: Our high-volume, single-center experiences in the UK

Ahmed Elshiekh, Nick M Matharu, Abhinav Vepa.


Objectives: This study aims to assess the feasibility of combined truncal endothermal ablation (ETA) and ultrasound-guided foam
sclerotherapy (UGFS) in a single treatment session and compare this technique to published re-intervention rates following truncal ablation
Patients and methods: The study was a retrospective data analysis of prospectively collected data. The patients had a preoperative US and
then Endothermal Ablation (ETA) with concomitant UGFS. The need for a secondary treatment, technical success, operation time, patient
satisfaction, complications, and recurrence were evaluated.
Results: The mean follow-up was 4.4±3.7 months. The technical success was achieved in all patients. Sixty-six (93%) of the patients did
not need further treatments. Five patients (7%) needed further interventions with repeated combined ETA and UGFS (n=1, 1.4%) and
sclerotherapy (n=4, 5.6%). These interventions did not increase the financial cost of treatment, compared to ETA alone.
Conclusion: Our study results suggest that one-stop dual therapy for the treatment of VV is associated with less need for further treatment,
compared to truncal ETA alone without increasing the treatment cost.

Key words: Endovenous therapy, varicose vein, venous ablation.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.